Clinical Trials on Ovarian Reserve Parameters

Total 5171 results

University Hospital, Basel, Switzerland
Roche Diagnostic Ltd.

Completed

Is the Concentration of Anti-Muellerian Hormon (AMH) Depending on the Menstrual Cycle? (Bicycle)

Ovarian Failure

Switzerland
ART Fertility Clinics LLC

Terminated

Progesterone Diurnal Rhythm During Ovarian Stimulation for IVF

Ovarian Hyperstimulation

United Arab Emirates
Tabriz University

Completed

The Effect of Oxytocin (OT) and Oxytocin Plus Human Chorionic Gonadotropin (hCG), in Cycles Induced by Letrozole or Clomiphene Citrate

Ovarian Response
Hospices Civils de Lyon

Completed

Low Grade Serous Ovarian Carcinoma and Uterine Involvement : Should Hysterectomy be the Rule (LOGYST)

Serous Ovarian Carcinoma | Low Grade Serous Ovarian Carcinoma

France
Dana-Farber Cancer Institute
Celula, Inc.

Terminated

Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis

Stage IV Ovarian Cancer | Stage III Ovarian Cancer

United States
Burzynski Research Institute

Terminated

Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer

Stage IV Ovarian Cancer | Stage III Ovarian Cancer

United States
University of Pennsylvania

Completed

How v. How and Why Nudges and Rewards

Control Condition | How Incentive Receive | How Incentive Holdout | How Incentive Ineligible | How and Why Incentive Receive | How and Why Incentive Holdout | How and Why Incentive Ineligible

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer

Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Serous Cystadenocarcinoma | Fallopian Tube Carcinoma | Primary Peritoneal Carcinoma | Malignant Ovarian Mixed Epithelial Tumor | Ovarian Brenner Tumor | Ovarian Mucinous Cystadenocarcinoma | Undifferentiated Ovarian... and other conditions

United States
CanariaBio Inc.

Terminated

The Safety and Antitumor Activity of the Combination of Oregovomab and Hiltonol in Recurrent Advanced Ovarian Cancer

Ovary Cancer | Ovarian Cancer Stage IV | Neoplasms, Ovarian | Ovarian Cancer Stage III | Ovarian Cancer Recurrent | Cancer of Ovary

United States
National Cancer Institute (NCI)
NRG Oncology

Completed

Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer

Ovarian Clear Cell Cystadenocarcinoma | Stage IV Ovarian Cancer | Stage III Ovarian Cancer

United States, Korea, Republic of, Japan
Tongji Hospital

Recruiting

A Multicenter Clinical Study of Yijing Keli in the Treatment of Ovarian Aging

Ovarian Aging

China
Minia University

Unknown

Effect of Controlled Ovarian Stimulation in Quality of Oocyte and Embryo

Ovarian Stimulation
Merck KGaA, Darmstadt, Germany

Completed

Lutropin Alfa in Women at Risk of Poor Response

Ovarian Stimulation

Spain
IVI Madrid

Completed

Human Chorionic Gonadotropin (hCG) Priming Prior to Controlled Ovarian Hyperstimulation (COH) in Poor Responder In Vitro Fertilization (IVF) Patients (APPE)

Ovarian Response

Spain
Yazd Research & Clinical Center for Infertility

Completed

Clomiphene Citrate (CC)/Gonadotropin/Gonadotropin Releasing Hormone (GnRH) Antagonist Versus Gonadotropin/GnRH Agonist

Ovarian Stimulation

Iran, Islamic Republic of
Instituto Valenciano de Infertilidad, IVI VALENCIA

Completed

Impact of Three Different Gonadotrophin Regimes on Egg Donation Program

Ovarian Stimulation

Spain
Hospital Clinic of Barcelona

Completed

Androgens for Poor Responders in In Vitro Fertilization

Ovarian Response

Spain
University Magna Graecia

Unknown

A New Algorithm to Predict Ovarian Age (OvAge)

Polycystic Ovary Syndrome | Ovarian Cysts | Infertility | Endometriosis | Premature Ovarian Failure (POF)

Italy
National Cancer Institute (NCI)
Gynecologic Oncology Group

Completed

Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)

Fallopian Tube Cancer | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Serous Cystadenocarcinoma | Stage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Brenner Tumor | Stage II Ovarian Epithelial Cancer | Stage III Ovarian Epithelial Cancer | Ovarian... and other conditions

United States
Daiichi Sankyo, Inc.

Completed

Combination Chemotherapy With CS-1008 to Treat Ovarian Cancer

Ovarian Cancer Stage IIIC | Ovarian Cancer Stage IV

United States
University Health Network, Toronto

Completed

A Study of the Safety, Tolerability and Effectiveness of Hydroxychloroquine and Itraconazole in Platinum-resistant Epithelial Ovarian Cancer

Platinum-resistant Epithelial Ovarian Cancer

Canada
Xian-Janssen Pharmaceutical Ltd.

Terminated

A Study to Compare CAELYX With Topotecan HCL in Patients With Recurrent Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy

Epithelial Ovarian Cancer

China
Biocad

Recruiting

DEFENDOR: A Multicenter Prospective Observational Post-registration stuDy of Extimia® (INN: empEgfilrastim) to Evaluate Efficacy and saFEty in patieNts With soliD tumORs (DEFENDOR)

Patients With Solid Tumours Who Receive Myelosupressive Therapy

Russian Federation
Gynecologic Oncology Group
National Cancer Institute (NCI)

Withdrawn

Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Responded to Second-Line Chemotherapy

Recurrent Ovarian Carcinoma | Fallopian Tube Carcinoma | Primary Peritoneal Carcinoma | Stage IV Ovarian Cancer | Stage III Ovarian Cancer

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Recurrent Ovarian Germ Cell Tumor | Undifferentiated Ovarian Carcinoma | Ovarian Serous...

United States
National Cancer Institute (NCI)

Completed

Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer

Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Serous Cystadenocarcinoma | Stage IV Ovarian Epithelial Cancer | Brenner Tumor | Stage III Ovarian Epithelial Cancer | Ovarian Mucinous Cystadenocarcinoma | Ovarian Mixed Epithelial Carcinoma | Ovarian Undifferentiated...

United States
University of Washington
National Cancer Institute (NCI)

Completed

Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy

Fallopian Tube Cancer | Peritoneal Cavity Cancer | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Serous Cystadenocarcinoma | Stage IV Ovarian Epithelial Cancer | Brenner Tumor | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial Cancer | Ovarian Mucinous... and other conditions

United States
University Health Network, Toronto

Completed

18F-DCFPyL PET/CT in High-grade Epithelial Ovarian Cancer (PET HOC)

Stage IV Ovarian Cancer | Stage III Ovarian Cancer

Canada
SOTIO a.s.

Completed

Phase II Study DCVAC/OvCa Added to First Line Carboplatin and Paclitaxel Newly Diagnosed Epithelial Ovarian Carcinoma

Ovarian Neoplasms | Ovarian Epithelial Cancer

Czechia, Poland
Yonsei University
National Cancer Center, Korea; Samsung Medical Center; AstraZeneca; Seoul National... and other collaborators

Unknown

A Phase II Study of Neoadjuvant Chemotherapy Plus Durvalumab (MEDI4736) and Tremelimumab in Advanced-stage Ovarian Cancer (TRU-D) (KGOG3046)

Ovarian Cancer Stage IIIC | Ovarian Cancer Stage IV

Korea, Republic of
Instituto Bernabeu

Completed

Conventional Ovarian Stimulation vs. Single Injection Stimulation of Corifollitropin Alfa in Oocyte Donor (TAIL)

Ovarian Stimulation

Spain
Assiut University

Unknown

Goserelin for Ovarian Protection in Premenopausal Patients Receiving Cyclophosphamide

Ovarian Failure
Universitaire Ziekenhuizen KU Leuven

Unknown

MAR With Artificial Gametes: Treatment Characteristics and Their Trade-offs Determining Treatment Preference

Ovarian Failure
Yazd Research & Clinical Center for Infertility

Completed

Antagonist/Letrozole in Poor Responders

Ovarian Stimulation

Iran, Islamic Republic of
Meir Medical Center

Completed

Dehydroepiandrosterone Supplementation for Poor Responder Patients During in Vitro Fertilization Treatment

Ovarian Stimulation

Israel
University of Saskatchewan
Canadian Institutes of Health Research (CIHR)

Completed

Mid-luteal Phase Synchronization of Ovarian Folliculogenesis in Women

Ovarian Follicle

Canada
Chinese University of Hong Kong

Recruiting

Clinical Application of Serum Anti-Müllerian Hormone (AMH) Measurements

Polycystic Ovarian Syndrome | Fertility Issues | Premature Ovarian Insufficiency | Anti-Müllerian Hormone

Hong Kong
Dana-Farber Cancer Institute

Recruiting

Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy

Ovarian Cancer | Endometrial Cancer | Ovarian Carcinoma | Ovarian Cancer Stage IV | Ovarian Cancer Stage III | Ovarian Cancer Stage 3 | Endometrial Cancer Stage

United States
Fundacion Clinic per a la Recerca Biomédica

Not yet recruiting

Sentinel Node Detection With Technetium-99m Albumin Nanocolloid and ICG in Patients With Epithelial Ovarian Cancer (Melisa-II)

Ovarian Epithelial Cancer
University of Minnesota

Completed

Interactive Educational Website for Women With Ovarian Cancer & Caregivers

Fallopian Tube Cancer | Recurrent Ovarian Cancer | Stage IV Ovarian Cancer | Stage III Ovarian Cancer

United States
National Cancer Institute (NCI)

Completed

Sorafenib Tosylate and Gemcitabine Hydrochloride in Treating Patients With Recurrent Epithelial Ovarian Cancer

Recurrent Ovarian Epithelial Cancer | Recurrent Primary Peritoneal Cavity Cancer

Canada
Cairo University

Completed

PCOS and US Cavitation

PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries

Egypt
National Cancer Institute (NCI)
Gynecologic Oncology Group

Completed

Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Fallopian Tube Cancer | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Serous Cystadenocarcinoma | Stage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Brenner Tumor | Stage II Ovarian Epithelial Cancer | Stage III Ovarian Epithelial Cancer | Ovarian... and other conditions

United States, Japan
Paul Speiser, Prof.MD,

Completed

Early Detection of High Grade Ovarian Cancer Using Uterine Lavage EHUD Study and Duplex Sequencing (EHUD)

Carcinoma in Situ | Ovarian Cancer | Ovarian Epithelial Cancer

Austria, Czechia, Germany, Ireland
Aivita Biomedical, Inc.

Active, not recruiting

Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Advanced Epithelial Ovarian Carcinomas

Fallopian Tube Carcinoma | Primary Peritoneal Carcinoma | Stage III Ovarian Carcinoma | Stage IV Ovarian Carcinoma

United States
Gradalis, Inc.

Completed

Salvage Ovarian FANG™ Vaccine + Bevacizumab

Stage IV Ovarian Cancer | Stage III Ovarian Cancer

United States
Mario Negri Institute for Pharmacological Research
Hoffmann-La Roche; PharmaMar

Completed

Bevacizumab and Trabectedin +/- Carboplatin in Advanced Ovarian Cancer

Ovarian Epithelial Cancer Recurrent

Italy
Cairo University

Recruiting

Assessment of Bone Quality After Socket Preservation Using Sodium Alendronate Gel Compared to Sticky Bone

Sticky Bone | Bone Quality Assessment | Preserved Sockets | Sodium Alendronate

Egypt
Zagazig University

Completed

Insulin Sensitizers Role in Control of PCOS Vicious Cycle.

PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries

Egypt
Medical University Innsbruck

Recruiting

Register to Describe the Treatment Pattern of Platinum-sensitive Relapsed Epithelial Ovarian Cancer Patients in Austria

Recurrent Ovarian Carcinoma

Austria

Clinical Trials on Ovarian Reserve Parameters

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Algeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations